| Luis R Castellanos, MD | |
|
200 W Arbor Dr, Division Of Cardiology, Mpf 360, San Diego, CA 92103-9001 | |
| (619) 543-8213 | |
| (619) 543-5576 |
| Full Name | Luis R Castellanos |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 200 W Arbor Dr, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013059286 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A89654 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uc San Diego Health Hillcrest - Hillcrest Med Ctr | San diego, CA | Hospital |
| El Centro Regional Medical Center | El centro, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imperial Valley Family Care Medical Group A P C | 0446243083 | 27 |
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
The finding, published on the preprint server medRxiv in June 2020, shows that it has been causing infection in Brazil long before the first case was reported in the Americas, North and South, in January 2020, and certainly before the first case in this Brazilian region.
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017. The study included 1.5 million women who were followed-up for more than 30 years.
Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.
What's more, the team demonstrated through studies in people and animals that inhalation of a 'souped up' form of nitric oxide, which targets red blood cells, reverses the blood abnormality to restore normal lung pressure.
› Verified 8 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578672184 PECOS PAC ID: 3577476761 Enrollment ID: O20031211000464 |
News Archive
The finding, published on the preprint server medRxiv in June 2020, shows that it has been causing infection in Brazil long before the first case was reported in the Americas, North and South, in January 2020, and certainly before the first case in this Brazilian region.
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017. The study included 1.5 million women who were followed-up for more than 30 years.
Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.
What's more, the team demonstrated through studies in people and animals that inhalation of a 'souped up' form of nitric oxide, which targets red blood cells, reverses the blood abnormality to restore normal lung pressure.
› Verified 8 days ago
| Entity Name | Imperial Valley Family Care Medical Group A P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275581894 PECOS PAC ID: 0446243083 Enrollment ID: O20040407001358 |
News Archive
The finding, published on the preprint server medRxiv in June 2020, shows that it has been causing infection in Brazil long before the first case was reported in the Americas, North and South, in January 2020, and certainly before the first case in this Brazilian region.
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017. The study included 1.5 million women who were followed-up for more than 30 years.
Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.
What's more, the team demonstrated through studies in people and animals that inhalation of a 'souped up' form of nitric oxide, which targets red blood cells, reverses the blood abnormality to restore normal lung pressure.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luis R Castellanos, MD Po Box 232410, Division Of Cardiology, Mpf 360, San Diego, CA 92193-2410 Ph: (619) 543-6222 | Luis R Castellanos, MD 200 W Arbor Dr, Division Of Cardiology, Mpf 360, San Diego, CA 92103-9001 Ph: (619) 543-8213 |
News Archive
The finding, published on the preprint server medRxiv in June 2020, shows that it has been causing infection in Brazil long before the first case was reported in the Americas, North and South, in January 2020, and certainly before the first case in this Brazilian region.
Big women have a nearly threefold greater risk of atrial fibrillation than small women, according to research presented today at EuroPrevent 2017. The study included 1.5 million women who were followed-up for more than 30 years.
Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.
What's more, the team demonstrated through studies in people and animals that inhalation of a 'souped up' form of nitric oxide, which targets red blood cells, reverses the blood abnormality to restore normal lung pressure.
› Verified 8 days ago
Dr. Ramin Motarjemi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 858-249-2500 Fax: 858-657-8069 | |
Dr. Shweta Warner, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-221-6258 Fax: 619-221-6012 | |
Dr. Matthew James Roosevelt, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, Department Of Hospital Medicine, San Diego, CA 92120 Phone: 619-952-5091 | |
Dr. Daniel Joseph Desantis, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: Naval Medical Ctr, 34800 Bob Wilson Dr., San Diego, CA 92134 Phone: 619-532-7935 | |
Kris Kumar, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Jedidiah Daniel Bell, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 619-471-0434 | |
Dr. Umber Dube, MD PHD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 8899 University Center Lane, Suite 350 Mc 0975, San Diego, CA 92122 Phone: 858-657-1675 |